Blood Test Could Help Predict Breast Cancer Immunotherapy Success With Liquid Biopsy Research

A new study suggests that a blood test may one day help predict which breast cancer patients are more likely to benefit from immunotherapy. This emerging liquid biopsy approach focuses on immune-related signals in the blood, especially T-cell activity, to better understand treatment response in patients with HER2-negative breast cancer. In this episode, we break down what this research means for breast cancer care and why it could become an important step toward more personalized cancer treat...